The American Medical Association (AMA) adopted policies which seek to provide patients with more detailed information about prescription drugs and address price hikes.
The AMA voted on the measures during its annual meeting in Chicago.
“Taken together, these policies would bring much-needed transparency to drug pricing and provide a clear benefit to consumers struggling with exorbitant costs,” AMA President-Elect Dr. Barbara McAneny said. “There seems to be no logic — or warning — to these price spikes.”
Among other things, the AMA also looks to push federal agencies to require manufacturers to list recommended retail prices of drugs during advertisements for consumers.
The health body also wants drug companies to provide a public notice before a price hike of more than 10 percent on medications.